Reopening AmericaReopening America

FDA Advisers Back Novavax Vaccine for Authorization

View descriptionShare

Vaccine experts advising the FDA have endorsed a new Covid vaccine made by Novavax saying that the shot’s benefits outweigh any risks associated with it.  The vaccine will still need full approval before coming on the market, but it will be the first one available using a more traditional, protein-based technology.  Liz Essley Whyte, reporter at the WSJ, joins us for what to know about its effectiveness and concerns.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Reopening America

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our  
Social links
Follow podcast
Recent clips
Browse 693 clip(s)